相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。AKT in cancer: new molecular insights and advances in drug development
Prabhjot S. Mundi et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2016)
Diabetes and Cancer: a Review of Current Knowledge
J. Wojciechowska et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2016)
Impact of metformin on metastases in patients with breast cancer and type 2 diabetes
Louis Jacob et al.
JOURNAL OF DIABETES AND ITS COMPLICATIONS (2016)
XGFR*, a novel affinity-matured bispecific antibody targeting IGF-1R and EGFR with combined signaling inhibition and enhanced immune activation for the treatment of pancreatic cancer
Juergen M. Schanzer et al.
MABS (2016)
The dual targeting of insulin and insulin-like growth factor 1 receptor enhances the mTOR inhibitor-mediated antitumor efficacy in hepatocellular carcinoma
Claudia Pivonello et al.
ONCOTARGET (2016)
Improvement of the BALB/c-3T3 cell transformation assay: a tool for investigating cancer mechanisms and therapies
Doerte Poburski et al.
SCIENTIFIC REPORTS (2016)
ERK1 and ERK2 Map Kinases: Specific Roles or Functional Redundancy?
Roser Busca et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2016)
Linsitinib (OSI-906) versus placebo for patients with locally advanced or metastatic adrenocortical carcinoma: a double-blind, randomised, phase 3 study
Martin Fassnacht et al.
LANCET ONCOLOGY (2015)
Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K
Rupert Courtnay et al.
MOLECULAR BIOLOGY REPORTS (2015)
The expanding role of mTOR in cancer cell growth and proliferation
Marie Cargnello et al.
MUTAGENESIS (2015)
Expression and clinical significance of mammalian target of rapamycin/P70 ribosomal protein S6 kinase signaling pathway in human colorectal carcinoma tissue
Qingjun Lu et al.
ONCOLOGY LETTERS (2015)
Phase I Study of Intermittent Oral Dosing of the Insulin-like Growth Factor-1 and Insulin Receptors Inhibitor OSI-906 in Patients With Advanced Solid Tumors
Robin L. Jones et al.
CLINICAL CANCER RESEARCH (2015)
A Phase I Study of Continuous Oral Dosing of OSI-906, a Dual Inhibitor of Insulin-Like Growth Factor-1 and Insulin Receptors, in Patients with Advanced Solid Tumors
Igor Puzanov et al.
CLINICAL CANCER RESEARCH (2015)
Effects of the Antitumor Drug OSI-906, a Dual Inhibitor of IGF-1 Receptor and Insulin Receptor, on the Glycemic Control, β-Cell Functions, and β-Cell Proliferation in Male Mice
Jun Shirakawa et al.
ENDOCRINOLOGY (2014)
Targeting RAS-ERK signalling in cancer: promises and challenges
Ahmed A. Samatar et al.
NATURE REVIEWS DRUG DISCOVERY (2014)
In vivo analysis of insulin-like growth factor type 1 receptor humanized monoclonal antibody MK-0646 and small molecule kinase inhibitor OSI-906 in colorectal cancer
Premila D. Leiphrakpam et al.
ONCOLOGY REPORTS (2014)
GSK-3 as potential target for therapeutic irvention in cancer
James A. McCubrey et al.
ONCOTARGET (2014)
Overcoming IGF1R/IR Resistance through Inhibition of MEK Signaling in Colorectal Cancer Models
Sara A. Flanigan et al.
CLINICAL CANCER RESEARCH (2013)
Insulin resistance and cancer: the role of insulin and IGFs
Sefirin Djiogue et al.
ENDOCRINE-RELATED CANCER (2013)
The decline and fall of the IGF-I receptor
Renato Baserga
JOURNAL OF CELLULAR PHYSIOLOGY (2013)
Overexpression of the Insulin Receptor Isoform A Promotes Endometrial Carcinoma Cell Growth
Chun-Fang Wang et al.
PLOS ONE (2013)
Latest insights into the risk of cancer in diabetes
Hiroshi Noto et al.
JOURNAL OF DIABETES INVESTIGATION (2013)
mTOR Signaling in Growth Control and Disease
Mathieu Laplante et al.
CELL (2012)
Obesity, type 2 diabetes, and cancer: the insulin and IGF connection
Dara Hope Cohen et al.
ENDOCRINE-RELATED CANCER (2012)
Wnt signaling from membrane to nucleus: β-catenin caught in a loop
Cara Jamieson et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2012)
Epithelial-Mesenchymal Transition Predicts Sensitivity to the Dual IGF-1R/IR Inhibitor OSI-906 in Hepatocellular Carcinoma Cell Lines
Hui Zhao et al.
MOLECULAR CANCER THERAPEUTICS (2012)
ECVAM prevalidation study on in vitro cell transformation assays: General outline and conclusions of the study
Raffaella Corvi et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2012)
Rodent cell transformation assays-A brief historical perspective
Leonard M. Schechtman
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2012)
Photo catalogue for the classification of foci in the BALB/c 3T3 cell transformation assay
Kiyoshi Sasaki et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2012)
Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis
Hiroshi Noto et al.
PLOS ONE (2012)
A Kinome-Wide Screen Identifies the Insulin/IGF-I Receptor Pathway as a Mechanism of Escape from Hormone Dependence in Breast Cancer
Emily M. Fox et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
18FDG-PET Predicts Pharmacodynamic Response to OSI-906, a Dual IGF-1R/IR Inhibitor, in Preclinical Mouse Models of Lung Cancer
Eliot T. McKinley et al.
CLINICAL CANCER RESEARCH (2011)
Lithium reduces tumorigenic potential in response to EGF signaling in human colorectal cancer cells
Flavia Vidal et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2011)
The AMPK signalling pathway coordinates cell growth, autophagy and metabolism
Maria M. Mihaylova et al.
NATURE CELL BIOLOGY (2011)
Diabetes Mellitus, Fasting Glucose, and Risk of Cause-Specific Death
Sreenivasa Rao Kondapally Seshasai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
Michelle C. Mendoza et al.
TRENDS IN BIOCHEMICAL SCIENCES (2011)
Genetic Dissection of the Oncogenic mTOR Pathway Reveals Druggable Addiction to Translational Control via 4EBP-eIF4E
Andrew C. Hsieh et al.
CANCER CELL (2010)
4E-BP1 Is a Key Effector of the Oncogenic Activation of the AKT and ERK Signaling Pathways that Integrates Their Function in Tumors
Qing-Bai She et al.
CANCER CELL (2010)
Comparison of gene expression profiles in BALB/c 3T3 transformed foci exposed to tumor promoting agents
Lin Ao et al.
TOXICOLOGY IN VITRO (2010)
BALB/c 3T3 cell transformation assay for the prediction of carcinogenic potential of chemicals and environmental mixtures
Maria Grazia Mascolo et al.
TOXICOLOGY IN VITRO (2010)
Insulin Receptor Isoforms and Insulin Receptor/Insulin-Like Growth Factor Receptor Hybrids in Physiology and Disease
Antonino Belfiore et al.
ENDOCRINE REVIEWS (2009)
Targeting the IGF1 axis in cancer proliferation
Ilan Bruchim et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2009)
Discovery of OSI-906: a selective and orally efficacious dual inhibitor of the IGF-I receptor and insulin receptor
Mark J. Mulvihill et al.
FUTURE MEDICINAL CHEMISTRY (2009)
Common corruption of the mTOR signaling network in human tumors
S Menon et al.
ONCOGENE (2009)
Identification of tumor promotion marker genes for predicting tumor promoting potential of chemicals in BALB/c 3T3 cells
Hideki Maeshima et al.
TOXICOLOGY IN VITRO (2009)
Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival
Jennifer H. Law et al.
CANCER RESEARCH (2008)
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
Ralph J. DeBerardinis et al.
CELL METABOLISM (2008)
A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor-dependent tumor growth in vivo
Qun-Sheng Ji et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Correlation of GLUT-1 overexpression, tumor size, and depth of invasion with 18F-2-fluoro-2-deoxy-D-glucose uptake by positron emission tomography in colorectal cancer
Jinyu Gu et al.
DIGESTIVE DISEASES AND SCIENCES (2006)
The Akt/PKB pathway: molecular target for cancer drug discovery
JQ Cheng et al.
ONCOGENE (2005)
Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody
Y Wang et al.
MOLECULAR CANCER THERAPEUTICS (2005)
Akt stimulates aerobic glycolysis in cancer cells
RL Elstrom et al.
CANCER RESEARCH (2004)
分享论文
